Why the study?
Does genetic overexpression of eNOS reduce myocardial infarct size and improve postischemic cardiac function in mice subjected to myocardial ischemia-reperfusion injury?
Population
Transgenic mice overexpressing the eNOS gene and non-transgenic mice subjected to 30 min of coronary artery…
Comparison
Genetic overexpression of eNOS vs Non-transgenic (NTG) mice
Design
Preclinical
Follow-up
Up to 7 days of reperfusion
Authors
Loading...
eNOS overexpression may limit infarct size in preclinical ischemia-reperfusion; leaves open functional recovery and clinical translation.
Does genetic overexpression of eNOS reduce myocardial infarct size and improve postischemic cardiac function in mice subjected to myocardial ischemia-reperfusion injury?
Genetic overexpression of eNOS in mice attenuates myocardial infarct size after ischemia-reperfusion injury but does not significantly protect against postischemic myocardial contractile dysfunction.
Jones et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: